(Q71011894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

S Segev

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

R Raz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

E Rubinstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

H Shmuely

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

D Hassin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

N Rosen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

E Platau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S Ben Assuli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S Pitlik

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 October 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

number of pages

5

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

851-855

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01691490

15 October 2019

exact match

0 references

cites work

Treatment of septic burns with a third-generation cephalosporin (cefatriaxon)

1 reference

12 December 2020

Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.

1 reference

12 December 2020

Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients

1 reference

12 December 2020

Treatment of various infections in an outpatient practice by intramuscular ceftriaxone: home parenteral therapy.

1 reference

12 December 2020

Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility

1 reference

12 December 2020

Once-daily ceftriaxone in the treatment of lower respiratory tract infections

1 reference

12 December 2020

Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.

1 reference

12 December 2020

Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study

1 reference

12 December 2020

Ceftriaxone therapy in otolaryngological and pulmonary infections

1 reference

12 December 2020

Outcome of a ceftriaxone/cefotaxime interchange programme in a major teaching hospital

1 reference

12 December 2020

Ceftriaxone in acute purulent exacerbations of chronic bronchitis

1 reference

12 December 2020

Human pharmacokinetics and distribution in various tissues of ceftriaxone

1 reference

12 December 2020

Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen

1 reference

12 December 2020

Once-daily ceftriaxone outpatient therapy in adults with infections

1 reference

12 December 2020

Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration

1 reference

12 December 2020

Antimicrobial activity of ceftriaxone: a review

1 reference

12 December 2020

Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections

1 reference

12 December 2020

APACHE II: a severity of disease classification system

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01691490

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605897%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference